HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.

AbstractBACKGROUND:
Photodynamic therapy (PDT) with 5-amino-4-oxo-pentanoate (methylaminolevulinate, MAL) is an effective and safe treatment option for actinic keratoses. Light-emitting diodes (LED) are suitable light sources for topical PDT. To evaluate the efficacy, painfulness, patient satisfaction and cosmesis of LED-based PDT a prospective, randomized and controlled split-face study was performed.
METHODS:
Topical ALA-PDT was administered to 17 patients whose actinic ker-atoses (n = 131) were symmetrically distributed and suitable for a two-side comparison. After incubation with MAL (16%), irradiation was performed with the incoherent lamp (160 mW cm(-2); 100 J cm(-2), PDT 1200L, Waldmann Medizintechnik, Villingen-Schwenningen, Germany) on one side and the LED system (120 mW cm(-2); 40 J cm(-2), LEDA, WaveLight AG, Erlangen, Germany) on the other side. The patients were followed by re-evaluation up to 6 months.
RESULTS:
Six months following treatment there was no significant difference between the infiltration and keratosis scores in both treatment regimes (p = 0.812). The remission rate was 78.5% (LED system) vs.80.3% (incoherent lamp). There was no significant difference between both light sources regarding the pain during therapy (p = 0.988). There was no significant difference between both treatment regimes regarding patient satisfaction (p = 1).
CONCLUSIONS:
LEDA-based MAL-PDT is an effective alternative for the treatment of atinic keratoses. The remission rates and cosmetic results are not inferior to PDT using incoherent light systems. Both treatment regimes are similarly painful.
AuthorsPhilipp Babilas, Richard Travnik, Annegret Werner, Michael Landthaler, Rolf-Markus Szeimies
JournalJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG (J Dtsch Dermatol Ges) Vol. 6 Issue 1 Pg. 25-32 (Jan 2008) ISSN: 1610-0387 [Electronic] Germany
PMID17995967 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Aminolevulinic Acid
Topics
  • Administration, Topical
  • Aged
  • Aged, 80 and over
  • Aminolevulinic Acid (administration & dosage)
  • Female
  • Humans
  • Keratosis (drug therapy, pathology)
  • Lighting (instrumentation, methods)
  • Male
  • Middle Aged
  • Photochemotherapy (methods)
  • Photosensitivity Disorders (drug therapy, pathology)
  • Semiconductors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: